Carrie K Jones Selected Research

Carrie K Jones Research Topics

Disease

34	Schizophrenia (Dementia Praecox) 11/2020 - 03/2005
13	Parkinson Disease (Parkinson's Disease) 10/2019 - 08/2009
12	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 10/2008
12	Catalepsy 10/2019 - 10/2008
9	Pain (Aches) 05/2019 - 09/2001
7	Hyperalgesia 02/2007 - 09/2001
4	Cognitive Dysfunction 01/2023 - 03/2005
4	Neurobehavioral Manifestations 01/2019 - 05/2010
3	Opioid-Related Disorders (Opiate Addiction) 01/2023 - 01/2019
3	Psychotic Disorders (Schizoaffective Disorder) 03/2015 - 06/2014
2	Substance-Related Disorders (Drug Abuse) 01/2019 - 03/2016
2	Rett Syndrome (Rett's Disorder) 01/2018 - 01/2017
2	Cocaine-Related Disorders (Cocaine Addiction) 03/2016 - 08/2013
2	Dyskinesias (Dyskinesia) 01/2016 - 08/2015
2	Fragile X Syndrome (Martin Bell Syndrome) 01/2016 - 09/2012
2	Autistic Disorder (Autism) 01/2016 - 09/2012
2	Seizures (Absence Seizure) 09/2013 - 08/2009
2	Central Nervous System Diseases (CNS Diseases) 09/2013 - 10/2008
2	Acute Pain 02/2005 - 09/2001
1	Alcoholism (Alcohol Abuse) 12/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2020
1	Syndrome (Syndromes) 01/2017
1	Neurodevelopmental Disorders 01/2017
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 03/2015
1	Brain Diseases (Brain Disorder) 02/2015
1	Infections 09/2014
1	Human Influenza (Influenza) 09/2014
1	Communicable Diseases (Infectious Diseases) 08/2013

Drug/Important Bio-Agent (IBA)

21	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 01/2023 - 09/2001
14	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2016 - 01/2005
11	Haloperidol (Haldol)FDA LinkGeneric 10/2019 - 11/2008
8	Cholinergic Agents (Cholinergics)IBA 01/2023 - 03/2005
7	CarrageenanIBA 02/2007 - 09/2001
5	Antipsychotic Agents (Antipsychotics)IBA 01/2019 - 10/2008
5	Capsaicin (Zostrix)FDA Link 10/2006 - 09/2001
4	Glutamate Receptors (Glutamate Receptor)IBA 12/2016 - 11/2012
4	Metabotropic Glutamate 5 ReceptorIBA 03/2016 - 12/2013
4	Muscarinic AgonistsIBA 01/2012 - 09/2001
3	Cholinergic ReceptorsIBA 01/2023 - 01/2012
3	Opioid Analgesics (Opioids)IBA 01/2023 - 01/2019
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021 - 11/2012
3	Acetylcholine (Acetylcholine Chloride)FDA Link 12/2020 - 01/2012
3	Analgesics (Analgesic Drugs)IBA 05/2019 - 01/2005
3	Morphine (MS Contin)FDA LinkGeneric 05/2019 - 02/2005
3	N-Methylaspartate (NMDA)IBA 12/2016 - 05/2015
3	Levodopa (L Dopa)FDA LinkGeneric 01/2016 - 02/2012
3	metabotropic glutamate receptor 4IBA 01/2016 - 08/2015
3	Glutamic Acid (Glutamate)FDA Link 08/2015 - 11/2012
3	Reserpine (Serpasil)FDA Link 03/2013 - 11/2008
3	metabotropic glutamate receptor 2IBA 01/2009 - 01/2005
3	Duloxetine Hydrochloride (Cymbalta)FDA Link 02/2007 - 02/2005
3	Formaldehyde (Formol)FDA Link 06/2005 - 09/2001
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2023 - 01/2012
2	Muscarinic M4 ReceptorIBA 12/2020 - 01/2018
2	VU0466551IBA 05/2019 - 01/2019
2	Dizocilpine Maleate (Dizocilpine)IBA 01/2018 - 03/2016
2	xanomelineIBA 01/2017 - 05/2010
2	N-(3-chlorophenyl)picolinamideIBA 08/2015 - 02/2012
2	Neurotransmitter Agents (Neurotransmitter)IBA 03/2015 - 12/2012
2	Amphetamine (Amfetamine)FDA LinkGeneric 03/2015 - 07/2014
2	ProdrugsIBA 12/2013 - 06/2005
2	Scopolamine (Hyoscine)FDA Link 03/2012 - 09/2001
2	N- (3- oxo- 3- (4- (pyridin- 4- yl)piperazin- 1- yl)propyl)benzo(c)(1,2,5)thiadiazole- 4- sulfonamideIBA 03/2012 - 08/2009
2	metabotropic glutamate receptor 3 (mGluR3)IBA 01/2009 - 07/2006
2	Ibuprofen (Motrin)FDA LinkGeneric 02/2007 - 02/2005
2	Acetic Acid (Vinegar)FDA LinkGeneric 02/2007 - 02/2005
1	VU6019650IBA 01/2022
1	VU0652957IBA 03/2019
1	Opioid Receptors (Opioid Receptor)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2018
1	VU0467485IBA 02/2017
1	VU0476406IBA 01/2017
1	Methyl-CpG-Binding Protein 2IBA 01/2017
1	LigandsIBA 01/2017
1	Clozapine (Clozaril)FDA LinkGeneric 03/2016
1	5- amino- 3,4- dimethyl- N- (4- ((trifluoromethyl)sulfonyl)benzyl)thieno(2,3- c)pyridazine- 6- carboxamideIBA 03/2016
1	Hypnotics and Sedatives (Sedatives)IBA 03/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	Therapeutic UsesIBA 01/2016
1	Dihydroxyphenylalanine (Dopa)IBA 08/2015
1	gamma-Aminobutyric Acid (GABA)IBA 08/2015
1	LSP1 2111IBA 08/2015
1	VU0409551IBA 06/2015
1	Neuropeptide YIBA 03/2015
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 03/2015
1	Serotonin (5 Hydroxytryptamine)IBA 03/2015
1	Exenatide (Byetta)FDA Link 12/2014
1	1-dodecylpyridoxal (PLD)IBA 09/2014
1	Phospholipase DIBA 09/2014
1	Cytochrome P-450 CYP3AIBA 12/2013
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 09/2013
1	VU0463841IBA 08/2013
1	Cocaine (Cocaine HCl)IBA 08/2013
1	metabotropic glutamate receptor 8IBA 03/2013
1	SaltsIBA 03/2013
1	ML253IBA 01/2013
1	benzocycloheptapyridineIBA 01/2013

Therapy/Procedure

2	Therapeutics 08/2013 - 12/2012
1	Drug Therapy (Chemotherapy) 03/2016
1	Oral Administration 12/2013